Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Iontophoretic Patch for Lateral Epicondylitis
NCT00794976Phase 2Completed
- Sponsor
- Travanti Pharma
- Start
- Oct 2008
- Primary completion
- May 2009
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone iontophoretic patch in Lateral Epicondylitis (LET) (4 arms), sponsored by Travanti Pharma. Primary endpoint: Pain severity assessed by VAS. Started Oct 2008; status: completed.
02
Drugs
dexamethasone iontophoretic patch
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT00794976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794976.